Reneural Technologies is a neurotechnology company that provides a neurorehabilitation platform called NeuroVive for stroke survivors. The platform integrates multiple technologies including VR, robotics, electromyography (EMG), and functional electrical stimulation (FES) to provide comprehensive rehabilitation services.
The company's solution focuses on physical, visual, cognitive, and mental health therapies through a single, cohesive platform that enables personalized, long-term care. It also allows therapists to set and adjust parameters before and during sessions to tailor therapy to patients' needs. The platform aims to facilitate early discharge from the hospital and improve patient engagement and compliance while supporting remote care delivery. The technology helps to improve patient outcomes, reduce healthcare costs, and ease the burden on clinicians.
In November 2022, the company secured support from Innovate UK's FastTrack program to build a proof of concept for its neurorehabilitation platform. The company planned to conduct its first clinical trials in January 2025 in partnership with the University of Hertfordshire.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.